Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-053206

EVP, R&D & Chief Scientific Of sold 6,000 shares at $15.30 ($91,800)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Haqq Christopher EVP, R&D & Chief Scientific Of 2017-09-15 Sale −6,000 $15.30 $91,800 349,305 D
Open-market sales · 6,000 sh · avg $15.30 · $91,800
Loading xslF345X03/doc4.xml…